Difference between revisions of "Team:Bielefeld-CeBiTec/Project/toolbox/fusing"

 
(22 intermediate revisions by 6 users not shown)
Line 4: Line 4:
 
<body>
 
<body>
 
<div class="container">
 
<div class="container">
−
<div class="contentbox">
+
<div id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/c/c8/T--Bielefeld-CeBiTec--title-img-fusing.jpg);">
−
<div class="bevel tr"></div>
+
<img src="https://static.igem.org/mediawiki/2017/c/c8/T--Bielefeld-CeBiTec--title-img-fusing.jpg">
−
<div class="content">
+
<div id="title-bg">
 +
<div id="title-text">
 +
Fusing
 +
</div>
 +
</div>
 +
</div>
 +
 
  
−
<!-- Ueberschriften -->
 
−
<h2> Fusing</h2>
 
−
        </div>
 
−
        </div>
 
−
</div>
 
 
<div class="contentbox">
 
<div class="contentbox">
 
<div class="bevel tr"></div>
 
<div class="bevel tr"></div>
Line 22: Line 23:
 
<!-- Normaler Text -->
 
<!-- Normaler Text -->
 
<article>
 
<article>
−
Fusing proteins is normally limited to the C- or N-terminus of a protein. The incorporation of non-canonical amino acids that could be fused to each other or to surfaces enables several additional applications. This tool facilitates immobilization of proteins and improved stability of protein polymer networks. Furthermore, they lead to enhanced efficiency of pathways by combining enzymes of one pathway or for any other system where colocalization is beneficial.
+
Fusing proteins is normally limited to the C&#x2011;&nbsp;or&nbsp;N&#x2011;terminus of a protein.  
−
<br>
+
The incorporation of non-canonical amino acids that could be fused to each  
−
As proof of concept, we work on enhanced stability of a protein polymer. This networks can be applied for different applications like modern biomaterials in medicine and industry (Rnjak-Kovacina et al., 2011). The amino acids N<sup>ε</sup>-L-cysteinyl-L-lysine (CL) and N<sup>γ</sup> 2 cyanobenzothiazol 6 yl L asparagine (CBT-Asp) comprise key parts of this tool. Both amino acids can bind specificly to each other resulting in the formation of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of silk elastin like proteins (SELPs). The strengthened polymer network would be a perfect material to produce biological wound bindings which are very thin and they would be able to interact with the natural tissue matrix (Boateng et al., 2008).
+
other or to surfaces enables several additional applications. Examples are the
 +
immobilization of proteins as well as improved stability of protein polymer networks.  
 +
Furthermore, it leads to enhanced efficiency of pathways by combining enzymes of  
 +
one pathway or for any other system where colocalization is beneficial.
 +
<br>
 +
As proof of concept, we work on enhanced stability of a protein polymer. These networks  
 +
can be applied for different applications like modern biomaterials in medicine and industry  
 +
(Rnjak-Kovacina&nbsp;<i>et&nbsp;al.</i>,&nbsp;2011). The amino acids <i>N</i><sup>ε</sup>&#x2011;L&#x2011;cysteinyl&#x2011;L&#x2011;lysine (CL)  
 +
and <i>N</i><sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine (CBT&#x2011;asparagine)  
 +
comprise key parts of this tool. Both amino acids can bind specifically to each other resulting in the formation  
 +
of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of  
 +
silk elastin like proteins (SELPs). The strengthened polymer network would be a perfect material to produce  
 +
biological wound bindings which are very thin and would be able to interact with the natural tissue matrix  
 +
(Boateng&nbsp;<i>et&nbsp;al.</i>,&nbsp;2008).
 
</article>
 
</article>
−
</div>
+
</div>
−
<div class="bevel bl"></div>
+
<div class="bevel bl"></div>
−
        </div>
+
 
</div>
 
</div>
 +
 
<div class="contentbox">
 
<div class="contentbox">
 
<div class="bevel tr"></div>
 
<div class="bevel tr"></div>
 
<div class="content">
 
<div class="content">
−
<h3>Terminus independent fusion proteins</h3>
+
<h3>Terminus independent fusion proteins</h3>
−
<article>
+
<article>
−
While terminus dependent binding systems for proteins are already in use, there are only a few systems for terminus independent binding systems. We want to expand the number of those systems. Our aim is to incorporate two non-canonical amino acids, which are able to build a specific bond to each other. According to the synthesis of luciferin for the firefly luciferase of <i>Photinus pyralis</i>, we decided to use the specific binding of 1,2-aminothiols and the cyano group of cyanobenzothiazole (CBT). Figure 1 shows the biosynthesis of luciferin and the mechanism of the binding reaction of CBT and 1,2-aminothiol.
+
While terminus dependent binding systems for proteins are already in use, there are only a  
−
</article>
+
few systems for terminus independent binding systems. We want to expand the number of those  
−
<!-- Mittleres zentriertes Bild -->
+
systems. Our aim is to incorporate two non-canonical amino acids, which are able to build a  
−
<div class="figure large">
+
specific bond to each other. According to the synthesis of D-luciferin for the firefly luciferase  
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/6/6f/T--Bielefeld-CeBiTec--27-08-17-luciferin_Liang2009.png">
+
of <i>Photinus&nbsp;pyralis</i>, we decided to use the specific binding of 1,2&#x2011;aminothiols  
−
<p class="figure subtitle"><b>Figure 1: Reaction of the 1,2-aminothiol of cysteine and CBT to luciferin (Liang et al., 2010).</b></p>
+
and the cyano group of cyanobenzothiazole&nbsp;(CBT). Figure 1 shows the biosynthesis of luciferin  
−
</div>
+
and the mechanism of the binding reaction of 1,2&#x2011;aminothiol and CBT.
 +
</article>
 +
<!-- Mittleres zentriertes Bild -->
 +
<div class="figure large">
 +
<img class="figure image" src="https://static.igem.org/mediawiki/2017/6/6f/T--Bielefeld-CeBiTec--27-08-17-luciferin_Liang2009.png">
 +
<p class="figure subtitle">
 +
<b>Figure 1: Reaction of the 1,2&#x2011;aminothiol of cysteine and  
 +
CBT to luciferin (Liang&nbsp;<i>et&nbsp;al.</i>,&nbsp;2010).</b>
 +
</p>
 +
</div>
 
 
−
<!-- Normaler Text -->
+
<!-- Normaler Text -->
−
<article>
+
−
By synthesis of amino acids with side chains containing CBT and a 1,2-aminothiol, polypeptides binding to each other should be produced. These amino acids are CL and CBT-Asp. The binding mechanism of both amino acids are shown in figure 2.
+
−
</article>
+
−
<!-- Mittleres zentriertes Bild -->
+
−
<div class="figure large">
+
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/f/f5/T--Bielefeld-CeBiTec--27-08-17-Specific_binding_CL_CBT-Asp.png">
+
−
<p class="figure subtitle"><b>Figure 2: Specific binding reaction of CL and CBT-Asp.</b></p>
+
−
</div>
+
−
<h3>N<sup>ε</sup>-L-cysteinyl-L-lysine</h3>
+
−
<article>
+
−
We synthesized CL in our lab and provide the community with a validated protocol. Currently, we are trying to synthesize CBT-Asp. Details of our synthesis protocol are described in the method section (link to methods).
+
−
</article>
+
−
 
+
−
 
+
−
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
+
−
<div class="contentline">
+
−
<div class="half left">
+
 
<article>
 
<article>
−
CL is an amino acid consisting of cysteine and lysine. The cysteine was coupled to the side chain of lysine so that CL contains a free 1,2-aminothiol group (Nguyen et al., 2011). This is an important characteristic for the specific binding between the CL and the CBT-Asp.  
+
By synthesis of amino acids with side chains containing CBT and a 1,2&#x2011;aminothiol, polypeptides
−
</article>
+
binding to each other should be produced. These amino acids are CL and CBT&#x2011;asparagine whose binding
−
+
mechanism is shown in figure 2.
 +
</article>
 +
<!-- Mittleres zentriertes Bild -->
 +
<div class="figure large">
 +
<img class="figure image" src="https://static.igem.org/mediawiki/2017/f/f5/T--Bielefeld-CeBiTec--27-08-17-Specific_binding_CL_CBT-Asp.png">
 +
<p class="figure subtitle">
 +
<b>Figure 2: Specific binding reaction of CL and CBT-asparagine.</b>
 +
</p>
 
</div>
 
</div>
−
<div class="half right">
+
<h3><i>N</i><sup>ε</sup>-L-cysteinyl-L-lysine</h3>
−
<div class="figure large">
+
<article>
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/2/22/T--Bielefeld-CeBiTec--27-08-17-CL_structure.png">
+
We synthesized CL and CBT&#x2011;asparagine in our lab. Additionally we are providing the community with a validated <a
−
<p class="figure subtitle"><b>Figure 3: Structure of CL.</b><br>Name: N<sup>ε</sup>-L-cysteinyl-L-lysine<br>
+
href="https://static.igem.org/mediawiki/2017/a/a6/T--Bielefeld-CeBiTec--protocol_CBT-asparagine.pdf">protocol for the synthesis of CBT&#x2011;asparagine</a>.
−
Molecular Weight: 249.33 g mol<sup>-1</sup><br>
+
</article>
−
Storage: -20 – 4 °C<br>
+
−
</p>
+
−
</div>
+
−
</div>
+
  
−
<h3>N<sup>γ</sup> 2 cyanobenzothiazol-6-yl-L-asparagine</h3>
 
−
<article>
 
−
CBT-Asp is a completely novel amino acid, which we are synthesizing on our own. to the synthesis is based on coupling the amino group of CBT to the carboxyl group of the side chain of L-asparagine. The cyano group of the cyanobenzothiazol enables the specific binding of the CBT-Asp to 1,2-aminothiols.
 
−
</article>
 
  
 +
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
 +
<div class="contentline">
 +
<div class="half left">
 +
<article>
 +
CL is an amino acid consisting of cysteine and lysine. The cysteine was coupled to the side
 +
chain of lysine so that CL contains a free 1,2-aminothiol group
 +
(Nguyen&nbsp;<i>et&nbsp;al.</i>,&nbsp;2011). This is an important characteristic for the
 +
specific binding between CL and CBT&#x2011;asparagine.
 +
<ul>
 +
<li>Name: <i>N</i><sup>ε</sup>-L-cysteinyl-L-lysine</li>
 +
<li>Short: CL
 +
<li>Molecular Weight: 249.33 g mol<sup>-1</sup></li>
 +
<li>Storage: -20 – 4 °C</li>
 +
<li>Function: Terminus independent binding system
 +
</ul>
 +
</article>
 +
 +
</div>
 +
<div class="half right">
 +
<div class="figure medium">
 +
<img class="figure image" src="https://static.igem.org/mediawiki/2017/2/22/T--Bielefeld-CeBiTec--27-08-17-CL_structure.png">
 +
<p class="figure subtitle">
 +
<b>Figure 3: Structure of CL.</b>
 +
</p>
 +
</div>
 +
</div>
  
−
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
+
<h3><i>N</i><sup>γ</sup>-2-cyanobenzothiazol-6-yl-L-asparagine</h3>
−
<div class="contentline">
+
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
−
<div class="half left">
+
<div class="contentline">
−
<div class="figure large">
+
<div class="half left">
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/2/22/T--Bielefeld-CeBiTec--27-08-17-CL_structure.png">
+
<div class="figure large">
−
<p class="figure subtitle"><b>Figure 4: Structure of CBT-Asp.</b><br>Name: N<sup>γ</sup>-2-cyanobenzothiazol-6-yl-L-asparagine<br>
+
<img class="figure image" src="https://static.igem.org/mediawiki/2017/6/64/T--Bielefeld-CeBiTec--27-08-17-CBT-Asp_structure.png">
−
Molecular Weight: 290.30 g mol<sup>-1</sup><br>
+
<p class="figure subtitle">
−
Storage: -20 – 4 °C<br>
+
<b>Figure 4: Structure of CBT&#x2011;asparagine.</b>
−
</p>
+
</p>
−
</div>
+
</div>
−
 
+
</div>
−
+
<div class="half right">
 +
<article>
 +
CBT&#x2011;asparagine is a completely novel amino acid, which we are synthesizing on our own. The synthesis is based on coupling the amino group of 6-Amino-CBT to the carboxyl
 +
group of the side chain of L-asparagine. The cyano group of the CBT enables the specific binding of the CBT&#x2011;asparagine to 1,2-aminothiols.
 +
<ul>
 +
<li>Name: <i>N</i><sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine</li>
 +
<li>Short: CBT&#x2011;asparagine
 +
<li>Molecular Weight: 290.30 g mol<sup>-1</sup></li>
 +
<li>Storage: -20 – 4 °C</li>
 +
<li>Function: Terminus independent binding system
 +
</ul>
 +
</article>
 +
</div>
 
</div>
 
</div>
−
<div class="half right">
 
−
<article>
 
−
CL is an amino acid consisting of cysteine and lysine. The cysteine was coupled to the side chain of lysine so that CL contains a free 1,2-aminothiol group (Nguyen et al., 2011). This is an important characteristic for the specific binding between the CL and the CBT-Asp.
 
−
</article>
 
−
 
−
</div>
 
−
</div>
 
−
        </div>
 
−
<div class="bevel bl"></div>
 
 
         </div>
 
         </div>
 +
<div class="bevel bl"></div>
 +
</div>
 
</div>
 
</div>
  
Line 112: Line 148:
 
<div class="bevel tr"></div>
 
<div class="bevel tr"></div>
 
<div class="content">
 
<div class="content">
−
 
 
<h3>Silk Elastin like Proteins</h3>
 
<h3>Silk Elastin like Proteins</h3>
−
 
+
<!-- Normaler Text -->
−
<!-- Normaler Text -->
+
 
<article>
 
<article>
−
This specific binding can improve the stability of SELPs. These are linear polypeptides with repeats of silk and elastin consensus sequences. They show brought application and possibilities in medicine, tissue engineering and industry (Rnjak-Kovacina et al., 2011). The silk consensus sequence is GAGAGS and the elastin consensus sequence is VPAVG. The consensus sequences can interact with each other and are able to form non-covalent hydrogen bonds. This results in a polymer network based on hydrogen bonds with a β-sheet structure. Figure 5 shows the schematic structure of a SELP polymer network.
+
This specific binding can improve the stability of SELPs. These are linear polypeptides with repeats of silk and elastin consensus  
−
</article>
+
sequences. They show broad applications in medicine, tissue engineering and industry  
−
 
+
(Rnjak-Kovacina&nbsp;<i>et&nbsp;al.</i>,&nbsp;2011). The silk consensus sequence is GAGAGS and the elastin consensus sequence is  
−
<div class="figure medium">
+
VPAVG. The consensus sequences can interact with each other and are able to form non-covalent hydrogen bonds. This results in a  
 +
polymer network based on hydrogen bonds with a β-sheet structure. Figure 5 shows the schematic structure of a SELP polymer network.
 +
</article>
 +
<div class="figure medium">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/3/36/T--Bielefeld-CeBiTec--27-08-17-Schematic_SELP.png">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/3/36/T--Bielefeld-CeBiTec--27-08-17-Schematic_SELP.png">
−
<p class="figure subtitle"><b>Figure 5: Schematic structure of a SELP polymer network.</b><br>Silk consensus sequences are shown in green, elastin consensus sequences are red and the blue lines show the hydrogen bonds of the consensus sequences.</p>
+
<p class="figure subtitle">
 +
<b>Figure 5: Schematic structure of a SELP polymer network.</b><br>Silk consensus sequences (GAGAGS) are shown in green,  
 +
elastin consensus sequences (VPAVG) in red and the blue lines indicate the hydrogen bonds of the consensus sequences.</p>
 
</div>
 
</div>
 +
<article>
 +
According to the work of Collins et al. (2013), we decided to use a sequence with nine repeats of five repeats of the silk consensus
 +
sequence and nine repeats of the elastin consensus sequence (see figure 6).
 +
</article>
  
−
<article>
+
<div class="figure medium">
−
According to the work of Collins et al. (2013), we decided to use a sequence with nine repeats of five repeats of the silk consensus sequence and nine repeats of the elastin consensus sequence (see figure 6).
+
<img class="figure image" src="https://static.igem.org/mediawiki/2017/b/b3/T--Bielefeld-CeBiTec--03-10-17-SELP_seq_Collins2013.png">
−
</article>
+
<p class="figure subtitle">
−
 
+
<b>Figure 6: Schematic sequence of the SELP (Collins&nbsp;<i>et&nbsp;al.</i>,&nbsp;2013).</b><br>Silk consensus sequences (S)
−
<div class="figure medium">
+
are shown in green and elastin consensus sequences (E) in red.</p>
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/0/0e/T--Bielefeld-CeBiTec--27-08-17-SELP_seq_Collins2013.png">
+
−
<p class="figure subtitle"><b>Figure 6: Schematic sequence of the SELP (Collins et al., 2013).</b><br>Silk consensus sequences are green and elastin consensus sequences are red.</p>
+
 
</div>
 
</div>
  
−
<article>
+
<article>
−
By incorporation of CL and CBT-Asp between the silk and the elastin repeats, we receive a strengthened polymer network with covalent bonds (Figure 7).
+
By incorporating CL and CBT&#x2011;asparagine between the silk and the elastin repeats, we receive a strengthened polymer network  
−
</article>
+
with covalent bonds (Figure 7).
 +
</article>
  
−
<div class="figure medium">
+
<div class="figure medium">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/9/9e/T--Bielefeld-CeBiTec--27-08-17-SELP_ncAA.png">
 
<img class="figure image" src="https://static.igem.org/mediawiki/2017/9/9e/T--Bielefeld-CeBiTec--27-08-17-SELP_ncAA.png">
−
<p class="figure subtitle"><b>Figure 7: Schematic structure of a SELP polymer network.</b></p>
+
<p class="figure subtitle">
 +
<b>Figure 7: Schematic structure of a SELP polymer network including CL and CBT-asparagine.</b><br>CL and CBT-asparagine (purple) are introduced between the silk (green) and elastin (red) repeats.</p>
 
</div>
 
</div>
 +
<h3>Recursive Directional Ligation by Plasmid Reconstruction (PRe-RDL)</h3>
 +
<article>
 +
The gene sequence for these SELPs has a high GC content and contains a high number of repeats leading to issues during synthesis.
 +
Therefore, PRe-RDL can be applied to address this challenge. PRe-RDL uses three restriction sites of a parent plasmid which contains the
 +
gene of interest (goi) and the subsequent ligation of fragments of two different restricted parent plasmids. The first step involves
 +
the restriction of a parent plasmid at the 3'-end of the goi and in the backbone. The second step is the restriction of a parent plasmid
 +
at the 5'-end of the goi and at the same position of the backbone as in the first step. The final step is the ligation of both generated
 +
fragments containing the goi. The result is a plasmid with two copies of the goi (Figure 5).
 +
</article>
 +
<div class="figure large">
 +
<img class="figure image" src="https://static.igem.org/mediawiki/2017/5/59/T--Bielefeld-CeBiTec--27-08-17-PRe-RDL_McDaniel2010.png">
 +
<p class="figure subtitle">
 +
<b>Figure 8: Scheme of the PRe-RDL according to McDaniel&nbsp;<i>et&nbsp;al.</i>,&nbsp;2010 and applied to pSB1C3 containing one elastin consensus sequence.</b> The Pre-RDL
 +
consists of 3 steps, two different digestions (step 1 and 2) and one ligation (step 3).</p>
 +
</div>
 +
<div class="article">
 +
Applied to pSB1C3 containing the consensus sequences of monomers and the spacers between the BioBrick prefix and suffix shown in figure 9, it is possible to use the PRe-RDL in
 +
combination with the restriction enzymes, <i>Acu</i>I, <i>Bse</i>RI, and <i>Bsp</i>EI, to build repetitive sequences of monomers.
 +
</div>
 +
<div class="figure large">
 +
<img class="figure image" src="https://static.igem.org/mediawiki/2017/f/f5/T--Bielefeld-CeBiTec--1-11-17_Design_elastin_silk.png">
 +
<p class="figure subtitle">
 +
<b>Figure 9: Design of <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201250">BBa_K2201250</a> and <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201251">BBa_K2201251</a>.</b> </p>
 +
</div>
 +
<div class="article">
 +
Step 1 serves to create a fragment containing one part of the chloramphenicol resistance (CmR) and the whole monomer consensus sequence. To do so, the plasmid has to be digested
 +
with <i>Acu</i>I and <i>Bsp</i>EI. The other fragments which are resulting from this step contain the other part of the CmR and each one part of the origin of replication (ori).
 +
This decreases the chance of religation of the three fragments originating from this step. For step 2, it is necessary to use <i>Bse</i>RI and <i>Bsp</i>EI. The result of this
 +
digestion is one fragment containing one part of the CmR and the spacer between the prefix and the monomer consensus sequence and one fragment with the other part of the CmR,
 +
the ori, and the monomer consensus sequence. By ligation of both fragments of step 1 and 2 containing the monomer consensus sequence (step 3) pSB1C3 with two repeats of the
 +
monomer consensus sequence results. By repeating these steps it is possible to create repetitive sequences consisting of monomeric consensus sequences. During the PRe-RDL it is also possible
 +
to add codons like the amber codon using primers. After the PRe-RDL it is important to add a start and a stop codon.
 +
</div>
  
−
<h3>PRe-RDL</h3>
+
      </div>
 +
<div class="bevel bl"></div>
 +
</div>
 +
</div>
  
−
<article>
 
−
The gene sequence for these SELPs has a high GC content and contains a high number of repeats leading to issues during synthesis. Therefore, Recursive Directional Ligation by Plasmid Reconstruction (PRe RDL) can be applied to address this challenge. Pre-RDL uses three restriction sites of a parent plasmid which contains the gene of interest (goi) and the subsequently ligation of fragments of two different restricted parent plasmids. The first step involves the restriction of a parent plasmid at the 3'-end of the goi and in the backbone. The second step is the restriction of a parent plasmid at the 5'-end of the goi and at the same position of the backbone as in the first step. The final step is the ligation of both generated fragments containing the goi. The result is a plasmid with two copies of the goi (Figure 5). We applied Pre-RDL to build a plasmid with the described SELP gene sequence.
 
−
</article>
 
  
−
<div class="figure medium">
 
−
<img class="figure image" src="https://static.igem.org/mediawiki/2017/5/59/T--Bielefeld-CeBiTec--27-08-17-PRe-RDL_McDaniel2010.png">
 
−
<p class="figure subtitle"><b>Figure 8: Scheme of the PRe-RDL (McDaniel et al., 2010).</b></p>
 
−
</div>
 
  
−
<article>
+
<div class="contentbox">
−
+
<div class="bevel tr"></div>
 +
<div class="content">
 +
<h3>References</h3>
 +
<!-- Normaler Text -->
 +
        <article>
 +
<b>Boateng, J., Matthews, K.H., Stevens, H.N.E., and Eccleston, G.M.</b> (2008). Wound Healing Dressings and Drug Delivery Systems: A Review. J. Pharm. Sci. <b>97</b>.
 
<br>
 
<br>
 
<br>
 
<br>
−
Boateng, J., Matthews, K.H., Stevens, H.N.E., Eccleston, G.M., 2008. Wound Healing Dressings and Drug Delivery Systems: A Review. J. Pharm. Sci. 97. doi:10.1002/jps21210
+
<b>Collins, T., Azevedo-silva, J., Costa, A., Branca, F., Machado, R., and Casal, M.</b> (2013). Batch production of a silk-elastin-like protein in E . coli BL21 ( DE3 ): key parameters for optimisation. Microb. Cell Fact. <b>12</b>: 1–16.
 
<br>
 
<br>
 
<br>
 
<br>
−
Collins, T., Azevedo-silva, J., Costa, A., Branca, F., Machado, R., Casal, M., 2013. Batch production of a silk-elastin-like protein in E . coli BL21 ( DE3 ): key parameters for optimisation. Microb. Cell Fact. 12, 1–16. doi:10.1186/1475-2859-12-21
+
<b>Liang, G., Ren, H., and Rao, J.</b> (2010). A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2: 54–60.
 
<br>
 
<br>
 
<br>
 
<br>
−
Liang, G., Ren, H., Rao, J., 2010. A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2, 54–60. doi:10.1038/nchem.480
+
<b>McDaniel, J.R., Mackay, J.A., Quiroz, F.G., and Chilkoti, A.</b> (2010). Recursive Directional Ligation by Plasmid Reconstruction allows Rapid and Seamless Cloning of Oligomeric Genes. <b>11</b>: 944–952.
 
<br>
 
<br>
 
<br>
 
<br>
−
McDaniel, J.R., Mackay, J.A., Quiroz, F.G., Chilkoti, A., 2010. Recursive Directional Ligation by Plasmid Reconstruction allows Rapid and Seamless Cloning of Oligomeric Genes 11, 944–952. doi:10.1021/bm901387t.Recursive
+
<b>Nguyen, D.P., Elliott, T., Holt, M., Muir, T.W., and Chin, J.W.</b> (2011). Genetically Encoded 1,2-Aminothiols Facilitate Rapid and Site-Specific Protein Labeling via a Bio-orthogonal Cyanobenzothiazole Condensation. J. Am. Chem. Soc. <b>133</b>: 11418–11421.
 
<br>
 
<br>
 
<br>
 
<br>
−
Nguyen, D.P., Elliott, T., Holt, M., Muir, T.W., Chin, J.W., 2011. Genetically Encoded 1,2-Aminothiols Facilitate Rapid and Site-Specific Protein Labeling via a Bio-orthogonal Cyanobenzothiazole Condensation. J. Am. Chem. Soc. 133, 11418–11421. doi:10.1021/ja203111c
+
<b>Rnjak-Kovacina, J., Daamen, W.F., Pierna, M., Rodríguez-Cabello, J.C., and Weiss, A.S.</b> (2011). Elastin Biopolymers. Compr. Biomater.: 329–346.
−
<br>
+
−
<br>
+
−
Rnjak-Kovacina, J., Daamen, W.F., Pierna, M., Rodríguez-Cabello, J.C., Weiss, A.S., 2011. Elastin Biopolymers. Compr. Biomater. 329–346. doi:http://dx.doi.org/10.1016/B978-0-08-055294-1.00071-4
+
  
−
</article>
+
−
+
</article>
−
</div>
+
</div>
−
<div class="bevel bl"></div>
+
<div class="bevel bl"></div>
−
</div>
+
 
</div>
 
</div>
 
</body>
 
</body>
 +
<script>
 +
$("#project").addClass("active");
 +
$("#project-toolbox").addClass("active");
 +
$("#project-toolbox-fusing").addClass("active");
 +
</script>
 
</html>
 
</html>
 
{{Team:Bielefeld-CeBiTec/Footer}}
 
{{Team:Bielefeld-CeBiTec/Footer}}

Latest revision as of 00:43, 2 November 2017

Fusing

Short summary

Fusing proteins is normally limited to the C‑ or N‑terminus of a protein. The incorporation of non-canonical amino acids that could be fused to each other or to surfaces enables several additional applications. Examples are the immobilization of proteins as well as improved stability of protein polymer networks. Furthermore, it leads to enhanced efficiency of pathways by combining enzymes of one pathway or for any other system where colocalization is beneficial.
As proof of concept, we work on enhanced stability of a protein polymer. These networks can be applied for different applications like modern biomaterials in medicine and industry (Rnjak-Kovacina et al., 2011). The amino acids Nε‑L‑cysteinyl‑L‑lysine (CL) and Nγ‑2‑cyanobenzothiazol‑6‑yl‑L‑asparagine (CBT‑asparagine) comprise key parts of this tool. Both amino acids can bind specifically to each other resulting in the formation of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of silk elastin like proteins (SELPs). The strengthened polymer network would be a perfect material to produce biological wound bindings which are very thin and would be able to interact with the natural tissue matrix (Boateng et al., 2008).

Terminus independent fusion proteins

While terminus dependent binding systems for proteins are already in use, there are only a few systems for terminus independent binding systems. We want to expand the number of those systems. Our aim is to incorporate two non-canonical amino acids, which are able to build a specific bond to each other. According to the synthesis of D-luciferin for the firefly luciferase of Photinus pyralis, we decided to use the specific binding of 1,2‑aminothiols and the cyano group of cyanobenzothiazole (CBT). Figure 1 shows the biosynthesis of luciferin and the mechanism of the binding reaction of 1,2‑aminothiol and CBT.

Figure 1: Reaction of the 1,2‑aminothiol of cysteine and CBT to luciferin (Liang et al., 2010).

By synthesis of amino acids with side chains containing CBT and a 1,2‑aminothiol, polypeptides binding to each other should be produced. These amino acids are CL and CBT‑asparagine whose binding mechanism is shown in figure 2.

Figure 2: Specific binding reaction of CL and CBT-asparagine.

Nε-L-cysteinyl-L-lysine

CL is an amino acid consisting of cysteine and lysine. The cysteine was coupled to the side chain of lysine so that CL contains a free 1,2-aminothiol group (Nguyen et al., 2011). This is an important characteristic for the specific binding between CL and CBT‑asparagine.
  • Name: Nε-L-cysteinyl-L-lysine
  • Short: CL
  • Molecular Weight: 249.33 g mol-1
  • Storage: -20 – 4 °C
  • Function: Terminus independent binding system

Figure 3: Structure of CL.

Nγ-2-cyanobenzothiazol-6-yl-L-asparagine

Figure 4: Structure of CBT‑asparagine.

CBT‑asparagine is a completely novel amino acid, which we are synthesizing on our own. The synthesis is based on coupling the amino group of 6-Amino-CBT to the carboxyl group of the side chain of L-asparagine. The cyano group of the CBT enables the specific binding of the CBT‑asparagine to 1,2-aminothiols.
  • Name: Nγ‑2‑cyanobenzothiazol‑6‑yl‑L‑asparagine
  • Short: CBT‑asparagine
  • Molecular Weight: 290.30 g mol-1
  • Storage: -20 – 4 °C
  • Function: Terminus independent binding system

Silk Elastin like Proteins

This specific binding can improve the stability of SELPs. These are linear polypeptides with repeats of silk and elastin consensus sequences. They show broad applications in medicine, tissue engineering and industry (Rnjak-Kovacina et al., 2011). The silk consensus sequence is GAGAGS and the elastin consensus sequence is VPAVG. The consensus sequences can interact with each other and are able to form non-covalent hydrogen bonds. This results in a polymer network based on hydrogen bonds with a β-sheet structure. Figure 5 shows the schematic structure of a SELP polymer network.

Figure 5: Schematic structure of a SELP polymer network.
Silk consensus sequences (GAGAGS) are shown in green, elastin consensus sequences (VPAVG) in red and the blue lines indicate the hydrogen bonds of the consensus sequences.

According to the work of Collins et al. (2013), we decided to use a sequence with nine repeats of five repeats of the silk consensus sequence and nine repeats of the elastin consensus sequence (see figure 6).

Figure 6: Schematic sequence of the SELP (Collins et al., 2013).
Silk consensus sequences (S) are shown in green and elastin consensus sequences (E) in red.

By incorporating CL and CBT‑asparagine between the silk and the elastin repeats, we receive a strengthened polymer network with covalent bonds (Figure 7).

Figure 7: Schematic structure of a SELP polymer network including CL and CBT-asparagine.
CL and CBT-asparagine (purple) are introduced between the silk (green) and elastin (red) repeats.

Recursive Directional Ligation by Plasmid Reconstruction (PRe-RDL)

The gene sequence for these SELPs has a high GC content and contains a high number of repeats leading to issues during synthesis. Therefore, PRe-RDL can be applied to address this challenge. PRe-RDL uses three restriction sites of a parent plasmid which contains the gene of interest (goi) and the subsequent ligation of fragments of two different restricted parent plasmids. The first step involves the restriction of a parent plasmid at the 3'-end of the goi and in the backbone. The second step is the restriction of a parent plasmid at the 5'-end of the goi and at the same position of the backbone as in the first step. The final step is the ligation of both generated fragments containing the goi. The result is a plasmid with two copies of the goi (Figure 5).

Figure 8: Scheme of the PRe-RDL according to McDaniel et al., 2010 and applied to pSB1C3 containing one elastin consensus sequence. The Pre-RDL consists of 3 steps, two different digestions (step 1 and 2) and one ligation (step 3).

Applied to pSB1C3 containing the consensus sequences of monomers and the spacers between the BioBrick prefix and suffix shown in figure 9, it is possible to use the PRe-RDL in combination with the restriction enzymes, AcuI, BseRI, and BspEI, to build repetitive sequences of monomers.

Figure 9: Design of BBa_K2201250 and BBa_K2201251.

Step 1 serves to create a fragment containing one part of the chloramphenicol resistance (CmR) and the whole monomer consensus sequence. To do so, the plasmid has to be digested with AcuI and BspEI. The other fragments which are resulting from this step contain the other part of the CmR and each one part of the origin of replication (ori). This decreases the chance of religation of the three fragments originating from this step. For step 2, it is necessary to use BseRI and BspEI. The result of this digestion is one fragment containing one part of the CmR and the spacer between the prefix and the monomer consensus sequence and one fragment with the other part of the CmR, the ori, and the monomer consensus sequence. By ligation of both fragments of step 1 and 2 containing the monomer consensus sequence (step 3) pSB1C3 with two repeats of the monomer consensus sequence results. By repeating these steps it is possible to create repetitive sequences consisting of monomeric consensus sequences. During the PRe-RDL it is also possible to add codons like the amber codon using primers. After the PRe-RDL it is important to add a start and a stop codon.

References

Boateng, J., Matthews, K.H., Stevens, H.N.E., and Eccleston, G.M. (2008). Wound Healing Dressings and Drug Delivery Systems: A Review. J. Pharm. Sci. 97.

Collins, T., Azevedo-silva, J., Costa, A., Branca, F., Machado, R., and Casal, M. (2013). Batch production of a silk-elastin-like protein in E . coli BL21 ( DE3 ): key parameters for optimisation. Microb. Cell Fact. 12: 1–16.

Liang, G., Ren, H., and Rao, J. (2010). A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2: 54–60.

McDaniel, J.R., Mackay, J.A., Quiroz, F.G., and Chilkoti, A. (2010). Recursive Directional Ligation by Plasmid Reconstruction allows Rapid and Seamless Cloning of Oligomeric Genes. 11: 944–952.

Nguyen, D.P., Elliott, T., Holt, M., Muir, T.W., and Chin, J.W. (2011). Genetically Encoded 1,2-Aminothiols Facilitate Rapid and Site-Specific Protein Labeling via a Bio-orthogonal Cyanobenzothiazole Condensation. J. Am. Chem. Soc. 133: 11418–11421.

Rnjak-Kovacina, J., Daamen, W.F., Pierna, M., Rodríguez-Cabello, J.C., and Weiss, A.S. (2011). Elastin Biopolymers. Compr. Biomater.: 329–346.